Live Breaking News & Updates on கொழுமியம்

Stay updated with breaking news from கொழுமியம். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

America Loosens Grip on Glycemic Control


email article
Glycemic control among Americans still isn t quite as good as it used to be, a new study indicated.
In a cross-sectional analysis of National Health and Nutrition Examination Survey (NHANES) data, the number of adults with diabetes achieving glycemic control a glycated hemoglobin (HbA1c) under 7% dropped in recent years, reported Elizabeth Selvin, PhD, MPH, of Johns Hopkins Bloomberg School of Public Health in Baltimore, and colleagues.
About 57% of adults were able to achieve glycemic control from 2007-2010, reaching peak levels, but this proportion dropped down to 50.5% by 2015-2018, the group wrote in the
In 1999-2002, only 44% of adults had an HbA1c under 7%. This later rose to 56.7% in 2003-2006. After the peak in 2007-2010, the proportion of patients achieving an HbA1c under 7% slowly declined, dropping off to 51.8% in 2011-2014, and then further down in 2015-2018. ....

New York , United States , Michael Fang , Elizabeth Selvin , Nutrition Examination Survey , National Health , Johns Hopkins Bloomberg School Of Public Health , Johns Hopkins Bloomberg School , Public Health , New England Journal , Mexican Americans , New York City , England Journal , Englj Med , High Cholesterol , Blood Pressure , Non Hdl Cholesterol , புதியது யார்க் , ஒன்றுபட்டது மாநிலங்களில் , மைக்கேல் ஃப்யாஂக் , எலிசபெத் செல்வின் , ஊட்டச்சத்து தேர்வு கணக்கெடுப்பு , தேசிய ஆரோக்கியம் , ஜான்ஸ் ஹாப்கின்ஸ் ப்ளூம்பெர்க் பள்ளி ஆஃப் பொது ஆரோக்கியம் , ஜான்ஸ் ஹாப்கின்ஸ் ப்ளூம்பெர்க் பள்ளி , பொது ஆரோக்கியம் ,

High levels of 'Good Cholesterol' can increase risk of death: Study


High levels of Good Cholesterol can increase risk of death: Study
High levels of Good Cholesterol can increase risk of death: Study
It Is A Known Fact That High Levels Of Good Cholesterol Are Considered To Be Beneficial For Health. However, The Excess Of The Same Can Put Your Health At Risk, As Per A New Study.
News Nation Bureau | Edited By : Abhishek Ranjit
| Updated on: 25 Aug 2017, 09:13:09 AM
New Delhi:
It is a known fact that high levels of good cholesterol are considered to be beneficial for health. However, the excess of the same can put your health at risk, as per a new study by researchers at the University of Copenhagen in Denmark. ....

New Delhi , Health Fitness News , University Of Copenhagen , Latest Lifestyle News , Fitness News , Download News Nation , Good Cholesterol , What Is Good Cholesterol , Hdl Good Cholesterol , Risk Of Death , Health News , Is Cholesterol Good For Health , Can Cholesterol Cause Death , Cholesterol And Death , புதியது டெல்ஹி , ஆரோக்கியம் உடற்பயிற்சி செய்தி , பல்கலைக்கழகம் ஆஃப் கோபெந்ஹேகந் , சமீபத்தியது வாழ்க்கை செய்தி , உடற்பயிற்சி செய்தி , பதிவிறக்க Tamil செய்தி தேசம் , நல்ல கொழுப்பு , என்ன இருக்கிறது நல்ல கொழுப்பு , எச்டிஎல் நல்ல கொழுப்பு , ஆபத்து ஆஃப் இறப்பு , ஆரோக்கியம் செய்தி , இருக்கிறது கொழுப்பு நல்ல க்கு ஆரோக்கியம் ,

OKYO Pharma LTD: OKYO Pharma has U.S. Patent Issued Covering its Lipid Conjugated Peptide Analogues for treating Ocular Pain and Inflammation


(1)
LONDON, Feb. 23, 2021 (GLOBE NEWSWIRE) OKYO Pharma Limited ( OKYO or the Company ), a biotechnology company focused on the development of novel drugs to treat inflammatory eye diseases and chronic ocular pain, today announced that patent No. 10,899,796 entitled Compounds and Methods for Treating Pain was issued by the United States Patent and Trademark Office ( USPTO ) on January 26, 2021. This patent covers a class of bovine adrenal medulla (BAM) peptides linked to specific lipids that demonstrate potential for treating symptoms of neuropathic pain, ocular pain, ocular inflammation and/or dry eye disease.
The work recited in this patent lays out the potential of this class of lipidated BAM analogues as non-opioid analgesics for ocular pain management without the side effects and potential abuse associated with opioid medications. The Company originally announced in February 2018 that it had obtained exclusive licenses from On Target Therapeutics LLC and Tufts ....

United States , United Kingdom , City Of , Robert Emmet , Garys Jacob , Willy Simon , Trademark Office , London Stock Exchange , Pharma Limited , Optiva Securities , Tufts Medical Center , United States Patent , Target Therapeutics , Official List , United Kingdom Financial Conduct Authority , Main Market , ஒன்றுபட்டது மாநிலங்களில் , ஒன்றுபட்டது கிஂக்டம் , நகரம் ஆஃப் , ராபர்ட் எமெட் , கறிச் ஜாகோப் , வில்லி சிமோன் , முத்திரை அலுவலகம் , லண்டன் ஸ்டாக் பரிமாற்றம் , பார்மா வரையறுக்கப்பட்டவை , டஃப்ட்ஸ் மருத்துவ மையம் ,

Nasal spray blocks COVID-19 infection in ferrets


Researchers at Cornell, Columbia University Irving Medical Center and Erasmus Medical Center in the Netherlands have developed a nasal formulation that blocks the spread of COVID-19 among ferrets – and are hopeful the formulation could have the same effect on humans, and potentially generate therapeutic treatments as well.
Ferrets are one of the best animal models for COVID-19, because they take the virus quite readily, and undergo both direct contact and airborne transmission. Ferrets, similar to humans, also generate antibodies against the virus, yet display limited clinical signs.
“This is a simple nasal formulation that we think can prevent the transmission of SARS-CoV-2 in humans,” said Chris Alabi, associate professor of chemical and biomolecular engineering and a co-senior author of the paper. “The beauty of the research is its simplicity. The ultimate goal is to create a nasal spray drug product that can be made widely available, one that can ....

Emilia Romagna , Sudipta Biswas , Chris Alabi , Columbia University Irving Medical Center , University Of Wisconsin , Harrington Discovery Institute , Researchers At Erasmus Medical Center , National Institutes Of Health , University Of Campania , Erasmus Medical Center , National Institutes , Sharon Golub Fund , Health Innovation Nucleation Fund , Pediatrics Department , Columbia University , எமிலியா ரோமேந , சூதிப்த பிஸ்வாஸ் , கிறிஸ் அலபி , கொலம்பியா பல்கலைக்கழகம் இவிஂக் மருத்துவ மையம் , பல்கலைக்கழகம் ஆஃப் விஸ்கான்சின் , ஹாரிங்டன் கண்டுபிடிப்பு நிறுவனம் , ஆராய்ச்சியாளர்கள் இல் ஈராஸ்மஸ் மருத்துவ மையம் , தேசிய நிறுவனங்கள் ஆஃப் ஆரோக்கியம் , பல்கலைக்கழகம் ஆஃப் காம்பானியா , ஈராஸ்மஸ் மருத்துவ மையம் , தேசிய நிறுவனங்கள் ,